Pharmaceutical Excipients


Posted by LLS Health Technical Team | 06/16/2020

Oral drug administration is critical for the delivery of drugs in various therapeutic areas, such as cardiovascular and pain management. It is considered the preferred route of administration due to its significant advantages, including being both painless and convenient. We sat down with Rajib Bhattacharjee, Lubrizol Life Science Health’s Global Market Manager for Oral Treatments, to discuss the importance of oral drug delivery and distinguishing your product in a crowded market, as well as innovation in the space of poorly water-soluble compounds, particularly amorphous solid dispersions.

 

Categories: Pharmaceutical Excipients

Posted by LLS Health Technical Team | 05/27/2020

The inherent structure and physiology of the eye make it difficult for drugs to reach the site of action and persist over time. Despite these constraints, ocular therapies continue to garner significant interest due to growing patient need. Drug product developers are actively seeking options for overcoming these barriers and effectively delivering ophthalmic drugs. 

Categories: Pharmaceutical Excipients

Posted by LLS Health Technical Team | 05/04/2020

The current regulatory landscape, or lack of an independent excipient approval pathway, may be limiting the entrance of new excipients in the market and, subsequently, new drug products. We sat down with the Director of Regulatory Strategy and Policy for Lubrizol Life Science Health (LLS Health), Meera Raghuram, to discuss the importance of novel excipients and recent actions taken by the FDA.

Categories: Pharmaceutical Excipients